photo free
Home Images Vectors Videos

Stock image Paxlovid Pfizer

stock image Paxlovid - new antiviral drug developed by Pfizer

Paxlovid - New Antiviral Drug Developed By Pfizer

Image, 5.8MB, 5168 × 3448 jpg
stock image New York, USA, November 2021: Pfizer Covid-19 Paxlovid treatment box isolated on a white background. Health and prevention.

New York, USA, November 2021: Pfizer Covid-19 Paxlovid Treatment Box Isolated On A White Background. Health And Prevention.

Image, 1.56MB, 3841 × 2772 jpg
stock image COVID-19 experimental antiviral drug PAXLOVID,pile of white pills with letters engraved on side,potential experimental WHO Coronavirus cure,pandemic outbreak crisis,isolated on blue background

COVID-19 Experimental Antiviral Drug PAXLOVID,pile Of White Pills With Letters Engraved On Side,potential Experimental WHO Coronavirus Cure,pandemic Outbreak Crisis,isolated On Blue Background

Image, 7.53MB, 5475 × 3650 jpg
stock image Prague,Czech republic- December 2 2023: Paxlovid box of medication with active substance Nirmatrelvir and ritonavir combination for COVID 19, cov19 treatment by Pfizer-new special blister-complience

Prague,Czech Republic- December 2 2023: Paxlovid Box Of Medication With Active Substance Nirmatrelvir And Ritonavir Combination For COVID 19, Cov19 Treatment By Pfizer-new Special Blister-complience

Image, 2.48MB, 3024 × 4032 jpg
stock image Prague,Czech republic- December 2 2023: Paxlovid box of medication with active substance Nirmatrelvir and ritonavir combination for COVID 19, cov19 treatment by Pfizer-new special blister-complience

Prague,Czech Republic- December 2 2023: Paxlovid Box Of Medication With Active Substance Nirmatrelvir And Ritonavir Combination For COVID 19, Cov19 Treatment By Pfizer-new Special Blister-complience

Image, 2.34MB, 4032 × 3024 jpg
stock image Prague,Czech republic- December 2 2023: Paxlovid box of medication with active substance Nirmatrelvir and ritonavir combination for COVID 19, cov19 treatment by Pfizer-new special blister-complience

Prague,Czech Republic- December 2 2023: Paxlovid Box Of Medication With Active Substance Nirmatrelvir And Ritonavir Combination For COVID 19, Cov19 Treatment By Pfizer-new Special Blister-complience

Image, 1.77MB, 3024 × 4032 jpg
stock image Prague,Czech republic- December 2 2023: Paxlovid box of medication with active substance Nirmatrelvir and ritonavir combination for COVID 19, cov19 treatment by Pfizer-new special blister-complience

Prague,Czech Republic- December 2 2023: Paxlovid Box Of Medication With Active Substance Nirmatrelvir And Ritonavir Combination For COVID 19, Cov19 Treatment By Pfizer-new Special Blister-complience

Image, 1.9MB, 4032 × 3024 jpg
stock image Prague,Czech republic- December 2 2023: Paxlovid box of medication with active substance Nirmatrelvir and ritonavir combination for COVID 19, cov19 treatment by Pfizer-new special blister-complience

Prague,Czech Republic- December 2 2023: Paxlovid Box Of Medication With Active Substance Nirmatrelvir And Ritonavir Combination For COVID 19, Cov19 Treatment By Pfizer-new Special Blister-complience

Image, 2.56MB, 4032 × 3024 jpg
stock image Prague,Czech republic- December 2 2023: Paxlovid box of medication with active substance Nirmatrelvir and ritonavir combination for COVID 19, cov19 treatment by Pfizer-new special blister-complience

Prague,Czech Republic- December 2 2023: Paxlovid Box Of Medication With Active Substance Nirmatrelvir And Ritonavir Combination For COVID 19, Cov19 Treatment By Pfizer-new Special Blister-complience

Image, 2.48MB, 4032 × 3024 jpg
stock image Prague,Czech republic- December 2 2023: Paxlovid box of medication with active substance Nirmatrelvir and ritonavir combination for COVID 19, cov19 treatment by Pfizer-new special blister-complience

Prague,Czech Republic- December 2 2023: Paxlovid Box Of Medication With Active Substance Nirmatrelvir And Ritonavir Combination For COVID 19, Cov19 Treatment By Pfizer-new Special Blister-complience

Image, 2.02MB, 4032 × 3024 jpg
stock image Prague,Czech republic- December 2 2023: Paxlovid box of medication with active substance Nirmatrelvir and ritonavir combination for COVID 19, cov19 treatment by Pfizer-new special blister-complience

Prague,Czech Republic- December 2 2023: Paxlovid Box Of Medication With Active Substance Nirmatrelvir And Ritonavir Combination For COVID 19, Cov19 Treatment By Pfizer-new Special Blister-complience

Image, 1.89MB, 3024 × 4032 jpg
stock image Prague,Czech republic- December 2 2023: Paxlovid box of medication with active substance Nirmatrelvir and ritonavir combination for COVID 19, cov19 treatment by Pfizer-new special blister-complience

Prague,Czech Republic- December 2 2023: Paxlovid Box Of Medication With Active Substance Nirmatrelvir And Ritonavir Combination For COVID 19, Cov19 Treatment By Pfizer-new Special Blister-complience

Image, 2.23MB, 3024 × 4032 jpg
stock image Prague,Czech republic- December 2 2023: Paxlovid box of medication with active substance Nirmatrelvir and ritonavir combination for COVID 19, cov19 treatment by Pfizer-new special blister-complience

Prague,Czech Republic- December 2 2023: Paxlovid Box Of Medication With Active Substance Nirmatrelvir And Ritonavir Combination For COVID 19, Cov19 Treatment By Pfizer-new Special Blister-complience

Image, 2.53MB, 4032 × 3024 jpg
stock image Prague,Czech republic- December 2 2023: Paxlovid box of medication with active substance Nirmatrelvir and ritonavir combination for COVID 19, cov19 treatment by Pfizer-new special blister-complience

Prague,Czech Republic- December 2 2023: Paxlovid Box Of Medication With Active Substance Nirmatrelvir And Ritonavir Combination For COVID 19, Cov19 Treatment By Pfizer-new Special Blister-complience

Image, 1.9MB, 4032 × 3024 jpg
stock image Prague,Czech republic- December 2 2023: Paxlovid box of medication with active substance Nirmatrelvir and ritonavir combination for COVID 19, cov19 treatment by Pfizer-new special blister-complience

Prague,Czech Republic- December 2 2023: Paxlovid Box Of Medication With Active Substance Nirmatrelvir And Ritonavir Combination For COVID 19, Cov19 Treatment By Pfizer-new Special Blister-complience

Image, 2.5MB, 4032 × 3024 jpg
stock image Prague,Czech republic- December 2 2023: Paxlovid box of medication with active substance Nirmatrelvir and ritonavir combination for COVID 19, cov19 treatment by Pfizer-new special blister-complience

Prague,Czech Republic- December 2 2023: Paxlovid Box Of Medication With Active Substance Nirmatrelvir And Ritonavir Combination For COVID 19, Cov19 Treatment By Pfizer-new Special Blister-complience

Image, 1.77MB, 3024 × 4032 jpg
stock image Prague,Czech republic- December 2 2023: Paxlovid box of medication with active substance Nirmatrelvir and ritonavir combination for COVID 19, cov19 treatment by Pfizer-new special blister-complience

Prague,Czech Republic- December 2 2023: Paxlovid Box Of Medication With Active Substance Nirmatrelvir And Ritonavir Combination For COVID 19, Cov19 Treatment By Pfizer-new Special Blister-complience

Image, 1.94MB, 4032 × 3024 jpg
stock image Prague,Czech republic- December 2 2023: Paxlovid box of medication with active substance Nirmatrelvir and ritonavir combination for COVID 19, cov19 treatment by Pfizer-new special blister-complience

Prague,Czech Republic- December 2 2023: Paxlovid Box Of Medication With Active Substance Nirmatrelvir And Ritonavir Combination For COVID 19, Cov19 Treatment By Pfizer-new Special Blister-complience

Image, 1.92MB, 4032 × 3024 jpg
stock image Prague,Czech republic- December 2 2023: Paxlovid box of medication with active substance Nirmatrelvir and ritonavir combination for COVID 19, cov19 treatment by Pfizer-new special blister-complience

Prague,Czech Republic- December 2 2023: Paxlovid Box Of Medication With Active Substance Nirmatrelvir And Ritonavir Combination For COVID 19, Cov19 Treatment By Pfizer-new Special Blister-complience

Image, 1.91MB, 4032 × 3024 jpg
stock image Prague,Czech republic- December 2 2023: Paxlovid box of medication with active substance Nirmatrelvir and ritonavir combination for COVID 19, cov19 treatment by Pfizer-new special blister-complience

Prague,Czech Republic- December 2 2023: Paxlovid Box Of Medication With Active Substance Nirmatrelvir And Ritonavir Combination For COVID 19, Cov19 Treatment By Pfizer-new Special Blister-complience

Image, 2.36MB, 4032 × 3024 jpg
stock image New York, USA, November 2021: Pfizer Covid-19 Paxlovid treatment box isolated on a white background. Health and prevention.

New York, USA, November 2021: Pfizer Covid-19 Paxlovid Treatment Box Isolated On A White Background. Health And Prevention.

Image, 2.26MB, 4471 × 2960 jpg
stock image Female UK NHS GP general practitioner doctor wearing protective face mask,gloves,holding blue pill,selective macro detail focus,patient cure and remedy for illness or disease,prescription drug concept

Female UK NHS GP General Practitioner Doctor Wearing Protective Face Mask,gloves,holding Blue Pill,selective Macro Detail Focus,patient Cure And Remedy For Illness Or Disease,prescription Drug Concept

Image, 8.72MB, 5584 × 3632 jpg
stock image Paxlovid - new antiviral drug developed by Pfizer

Paxlovid - New Antiviral Drug Developed By Pfizer

Image, 5.89MB, 5168 × 3448 jpg
stock image New York, USA - 08 November 2020. Concept of antiviral pill against coronavirus disease. COVID drugs on a medical glass table. Selective focus

New York, USA - 08 November 2020. Concept Of Antiviral Pill Against Coronavirus Disease. COVID Drugs On A Medical Glass Table. Selective Focus

Image, 4.61MB, 4095 × 2886 jpg
stock image Bucharest, Romania - February 1, 2022: Illustrative editorial concept image of oral antiviral drug pill Paxlovid developed by Pfizer. Corona virus Covid-19 treatment.

Bucharest, Romania - February 1, 2022: Illustrative Editorial Concept Image Of Oral Antiviral Drug Pill Paxlovid Developed By Pfizer. Corona Virus Covid-19 Treatment.

Image, 7.27MB, 6516 × 4344 jpg
stock image Paxlovid, prescription treatment for COVID-19. It contains the antiviral medications nirmatrelvir and ritonavir and was developed by Pfizer.

Paxlovid, Prescription Treatment For COVID-19. It Contains The Antiviral Medications Nirmatrelvir And Ritonavir And Was Developed By Pfizer.

Image, 2.59MB, 7333 × 4479 jpg
stock image Uzice, SERBIA - Dec 22nd 2021: Medical worker holding medicine package box, Pfizer PAXLOVID antiviral drug,cure for Coronavirus infection,COVID-19 virus disease prevention and protection, illustration

Uzice, SERBIA - Dec 22nd 2021: Medical Worker Holding Medicine Package Box, Pfizer PAXLOVID Antiviral Drug,cure For Coronavirus Infection,COVID-19 Virus Disease Prevention And Protection, Illustration

Image, 8.93MB, 5530 × 3687 jpg
stock image Paxlovid - new antiviral drug developed by Pfizer

Paxlovid - New Antiviral Drug Developed By Pfizer

Image, 16.45MB, 7952 × 5304 jpg
stock image Bucharest, Romania - February 1, 2022: Illustrative editorial concept image of oral antiviral drug pill Paxlovid developped by Pfizer. Corona virus Covid-19 treatment.

Bucharest, Romania - February 1, 2022: Illustrative Editorial Concept Image Of Oral Antiviral Drug Pill Paxlovid Developped By Pfizer. Corona Virus Covid-19 Treatment.

Image, 10.83MB, 6720 × 4480 jpg
stock image Female UK pharmacist wearing PPE personal protective equipment,coveralls,face mask,eyewear,glove,holding blue pill,selective focus,patient cure and remedy for illness disease,prescription drug concept

Female UK Pharmacist Wearing PPE Personal Protective Equipment,coveralls,face Mask,eyewear,glove,holding Blue Pill,selective Focus,patient Cure And Remedy For Illness Disease,prescription Drug Concept

Image, 5.3MB, 5451 × 3634 jpg
stock image Province of Florence, Italy, 7th December 2021, close up of the pill anti covid by Pfizer, called Paxlovid.

Province Of Florence, Italy, 7th December 2021, Close Up Of The Pill Anti Covid By Pfizer, Called Paxlovid.

Image, 9.59MB, 5184 × 3456 jpg
stock image United States - december, 16, 2021 Pfizers Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89 in Interim Analysis of Phase 23 EPIC-HR Study

United States - December, 16, 2021 Pfizers Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89 In Interim Analysis Of Phase 23 EPIC-HR Study

Image, 7.05MB, 4720 × 4558 jpg
stock image New York, USA - 08 November 2020. Concept of antiviral pill against coronavirus disease. COVID drugs on a medical glass table. Selective focus

New York, USA - 08 November 2020. Concept Of Antiviral Pill Against Coronavirus Disease. COVID Drugs On A Medical Glass Table. Selective Focus

Image, 3.34MB, 4202 × 2876 jpg
stock image Paxlovid - new antiviral drug developed by Pfizer

Paxlovid - New Antiviral Drug Developed By Pfizer

Image, 6.92MB, 5168 × 3448 jpg
stock image Paxlovid - new antiviral drug developed by Pfizer

Paxlovid - New Antiviral Drug Developed By Pfizer

Image, 4.66MB, 5168 × 3448 jpg
stock image Paxlovid tablets of Nirmatrelvir and Ritonavir  for CoVid 19 treatment

Paxlovid Tablets Of Nirmatrelvir And Ritonavir For CoVid 19 Treatment

Image, 5.9MB, 4242 × 2828 jpg
stock image MALAYSIA-CIRCA JULY 2022 :  A box of Paxlovid tablets manufactured by Pfizer Inc. Studies show that Paxlovid has been described to reduce severe illness up to 89%.

MALAYSIA-CIRCA JULY 2022 : A Box Of Paxlovid Tablets Manufactured By Pfizer Inc. Studies Show That Paxlovid Has Been Described To Reduce Severe Illness Up To 89%.

Image, 4.1MB, 3648 × 2736 jpg
stock image Bucharest, Romania - February 1, 2022: Illustrative editorial concept image of oral antiviral drug pill Paxlovid developed by Pfizer. Corona virus Covid-19 treatment.

Bucharest, Romania - February 1, 2022: Illustrative Editorial Concept Image Of Oral Antiviral Drug Pill Paxlovid Developed By Pfizer. Corona Virus Covid-19 Treatment.

Image, 4.05MB, 4089 × 6133 jpg
stock image MALAYSIA-CIRCA JULY 2022 :  A box of Paxlovid tablets manufactured by Pfizer Inc. Studies show that Paxlovid has been described to reduce severe illness up to 89%.

MALAYSIA-CIRCA JULY 2022 : A Box Of Paxlovid Tablets Manufactured By Pfizer Inc. Studies Show That Paxlovid Has Been Described To Reduce Severe Illness Up To 89%.

Image, 4.39MB, 3648 × 2736 jpg
stock image United States - december, 16, 2021: Paxlovid, Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR Study

United States - December, 16, 2021: Paxlovid, Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Image, 6.59MB, 4000 × 3250 jpg
stock image Izmir, Turkey -  November 5 2021: Pfizer Covid-19 Paxlovid treatment box and pills isolated on a blue background.

Izmir, Turkey - November 5 2021: Pfizer Covid-19 Paxlovid Treatment Box And Pills Isolated On A Blue Background.

Image, 9.87MB, 4500 × 3004 jpg
stock image New York, USA, January 2022: Pfizer Covid-19 Paxlovid treatment box isolated on a white background. Health and prevention.

New York, USA, January 2022: Pfizer Covid-19 Paxlovid Treatment Box Isolated On A White Background. Health And Prevention.

Image, 1.92MB, 4471 × 2960 jpg
stock image Paxlovid tablets of Nirmatrelvir and Ritonavir  for CoVid 19 treatment

Paxlovid Tablets Of Nirmatrelvir And Ritonavir For CoVid 19 Treatment

Image, 5.63MB, 4242 × 2828 jpg
stock image NEW YORK - SEPTEMBER 1 , 2022: Antiviral medication PAXLOVID (nirmatrelvir tablets; ritonavir tablets) now authorized for emergency as a Treatment Option for COVID-19

NEW YORK - SEPTEMBER 1 , 2022: Antiviral Medication PAXLOVID (nirmatrelvir Tablets; Ritonavir Tablets) Now Authorized For Emergency As A Treatment Option For COVID-19

Image, 7.75MB, 5119 × 3413 jpg
stock image Paxlovid tablets of Nirmatrelvir and Ritonavir  for CoVid 19 treatment

Paxlovid Tablets Of Nirmatrelvir And Ritonavir For CoVid 19 Treatment

Image, 10.06MB, 4242 × 2828 jpg
Page 1 >> Next